Consensus guidelines for the diagnosis and management of isolated sulfite oxidase deficiency and molybdenum cofactor deficiencies
Journal of Inherited Metabolic Disease · 2024-07 · 47 (4) · 598-623
DOI: 10.1002/jimd.12730 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 16.04.2024. Verfasst von Bernd C Schwahn und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Evolution & Genomic Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. Hauptthemen laut MEDLINE: Metal Metabolism, Inborn Errors, Sulfite Oxidase. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SSIEM, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Sulfite intoxication is the hallmark of four ultrarare disorders that are caused by impaired sulfite oxidase activity due to genetic defects in the synthesis of the molybdenum cofactor or of the apoenzyme sulfite oxidase. Delays on the diagnosis of these disorders are common and have been caused by their unspecific presentation of acute neonatal encephalopathy with high early mortality, followed by the evolution of dystonic cerebral palsy and also by the lack of easily available and reliable diagnostic tests. There is significant variation in survival and in the quality of symptomatic management of affected children. One of the four disorders, molybdenum cofactor deficiency type A (MoCD‐A) has recently become amenable to causal treatment with synthetic cPMP (fosdenopterin). The evidence base for the rational use of cPMP is very limited. This prompted the formulation of these clinical guidelines to facilitate diagnosis and support the management of patients. The guidelines were developed by experts in diagnosis and treatment of sulfite intoxication disorders. It reflects expert consensus opinion and evidence from a systematic literature search.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Evolution & Genomic Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
- Manchester Centre for Genomic Medicine, Saint Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
- Department of Metabolic Diseases, Beatrix Children's, University Medical Center (UMC) Groningen, Groningen, Netherlands.
- Massachusetts General Hospital Department of Neurology, Boston, Massachusetts, USA.
- Department of Paediatric Radiology, Royal Manchester Children's Hospital, Manchester University Hospitals NHS Foundation Trust, University of Manchester, Manchester, UK.
- Division of Informatics, Imaging & Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
ORCID-Profile: Bernd C Schwahn
Förderung
- SSIEM
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Schwahn, B. C., van Spronsen, F., Misko, A., Pavaine, J., Holmes, V., Spiegel, R., Schwarz, G., Wong, F., Horman, A., Pitt, J., Sass, J. O., & Lubout, C. (2024). Consensus guidelines for the diagnosis and management of isolated sulfite oxidase deficiency and molybdenum cofactor deficiencies. Journal of Inherited Metabolic Disease, 47(4), 598-623. https://doi.org/10.1002/jimd.12730
Vancouver
Schwahn BC, van Spronsen F, Misko A, Pavaine J, Holmes V, Spiegel R, et al. Consensus guidelines for the diagnosis and management of isolated sulfite oxidase deficiency and molybdenum cofactor deficiencies. Journal of Inherited Metabolic Disease. 2024;47(4):598-623. doi:10.1002/jimd.12730
BibTeX
@article{Schwahn2024,
author = {Schwahn, Bernd C and van Spronsen, Francjan and Misko, Albert and Pavaine, Julija and Holmes, Victoria and Spiegel, Ronen and Schwarz, Guenter and Wong, Flora and Horman, Alistair and Pitt, James and Sass, Jörn Oliver and Lubout, Charlotte},
title = {Consensus guidelines for the diagnosis and management of isolated sulfite oxidase deficiency and molybdenum cofactor deficiencies},
journal = {Journal of Inherited Metabolic Disease},
year = {2024},
volume = {47},
number = {4},
pages = {598--623},
doi = {10.1002/jimd.12730}
}
EUVIMED